All In Biotech

Drug Trial Radar · NCT02522325

Reinforcing Effects of Cocaine During Phendimetrazine Maintenance

Behavioral Effects of Drugs (Inpatient): 31 (Cocaine and Phendimetrazine)

Last checked: Nov 20, 2026Latest source record: Jul 2, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

30

Actual

Start

Aug 2015

Primary completion

Dec 2018

Study completion Dec 2018

Sponsor

Lead sponsor
William StoopsAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Institute on Drug Abuse (NIDA)
First posted
Aug 13, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Crossover
Masking
Triple (participant, care provider, outcomes assessor)
Primary purpose
Basic science
Who can join
All sexes, from 18 years, up to 55 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study will determine the initial efficacy of phendimetrazine as a pharmacotherapy for cocaine dependence. A rigorous, inpatient human laboratory study will be conducted in which the subjective, physiological and reinforcing effects of cocaine are evaluated during maintenance on placebo and phendimetrazine.

Conditions

  • Cocaine Use Disorder

Interventions

  • PhendimetrazineDrug

    Phendimetrazine will be administered in divided doses twice daily.

  • CocaineDrug

    Intranasal cocaine will be administered during experimental sessions.

  • PlaceboDrug

    Placebo capsules will contain only cornstarch.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Times Cocaine Was Selected in the Presence of a Monetary Reward AlternativeTime frame: After at least seven days of maintenance placebo or target phendimetrazine dose

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University of Kentucky Department of Behavioral Science

    Lexington, Kentucky

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.